Welcome to our dedicated page for AXON ENTERPRISE SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AXON ENTERPRISE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AXON ENTERPRISE's regulatory disclosures and financial reporting.
GARNREITER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Michael Garnreiter reported equity compensation awards rather than open-market trades. On May 29, 2026, he received two grants of common stock totaling several hundred shares at $0.00 per share as part of his director compensation. A footnote explains these are time-vested restricted stock units granted under Axon’s Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual Meeting of Shareholders. These transactions reflect routine, plan-based stock awards instead of discretionary buying or selling of Axon shares.
Brown Adriane M reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Adriane M. Brown received an equity grant of 611 shares of Common Stock on May 29, 2026 as a compensation award. The shares are in the form of time-vested restricted stock units granted under the company’s Amended and Restated 2022 Stock Incentive Plan.
The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders. Following this grant, Brown directly holds 8,437 shares of Axon common stock, indicating a relatively small, routine director equity award rather than an open-market transaction.
Nardini Erika reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Erika Nardini received an equity grant of 611 shares of Common Stock through time-vested restricted stock units. The award was granted at no cash cost to her and increased her direct holdings to 2,557 shares of Axon common stock.
The restricted stock units were granted under Axon’s Amended and Restated 2022 Stock Incentive Plan and are scheduled to vest in full on the earlier of the one-year anniversary of the May 29, 2026 grant date and the date of Axon’s 2027 Annual Meeting of Shareholders.
Morgan Stanley Smith Barney LLC submitted a Rule 144 notice regarding AXON common stock. The filing lists two blocks of restricted stock vesting under a registered plan: 150 shares dated 03/16/2026 and 256 shares dated 05/13/2024. The filing also reports a sale of 157 shares on 03/17/2026 by Jeri L Williams, with proceeds shown as $76,917.72.
AXON reported a Form 144 notice for proposed sales of Common stock. The filing lists 446 shares tied to restricted stock vesting on 05/28/2026 and 118 shares tied to restricted stock vesting on 05/20/2023. The filer is Morgan Stanley Smith Barney LLC Executive Financial Services.
Axon Enterprise, Inc. reported results of its 2026 Annual Meeting of Shareholders. A total of 72,920,923 common shares were voted, representing approximately 90.5% of the 80,572,201 shares outstanding as of the March 31, 2026 record date. Shareholders elected nine directors to one-year terms, with each nominee receiving at least about 55.8 million votes in favor. They approved on an advisory basis the compensation of the named executive officers and ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accountant for fiscal year 2026, with 72,672,121 votes in favor.
AXON ENTERPRISE, INC. Chief Legal Officer Isaiah Fields reported an open-market sale of 2,000 shares of Common Stock on 2026-05-22 at a price of $400.00 per share. After this transaction, he directly holds 52,813.282 shares, indicating he retained a substantial position in the company.
AXON affiliate filing reports proposed/resale activity in 2,000 common shares tied to performance stock units dated 05/18/2023. The excerpt shows a sale of 2,000 shares by Isaiah Fields on 02/27/2026 for $1,070,016.60.
Axon Enterprise, Inc. filed a Form 13F reporting institutional holdings. The filing lists 1 reported position and a Form 13F Information Table value total of $18,051,979. The report is signed by Isaiah Fields, Chief Legal Officer, on 05-15-2026.
The submission certifies that the signer is authorized and that the information is true, correct, and complete. No other included managers are listed.